United States Medicine In Prostate Cancer Market Report 2016

September 2016 | 116 pages | ID: U414E8A03A9EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Medicine In Prostate Cancer

Revenue, means the sales value of Medicine In Prostate Cancer

This report studies sales (consumption) of Medicine In Prostate Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bristol-Myers Squibb
• AstraZeneca
• Eli Lilly
• Roche
• GSK
• Novartis
• Pfizer
• Sanofi
• Bayer
• Celgene

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Medicine In Prostate Cancer in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Medicine In Prostate Cancer Market Report 2016

1 MEDICINE IN PROSTATE CANCER OVERVIEW

1.1 Product Overview and Scope of Medicine In Prostate Cancer
1.2 Classification of Medicine In Prostate Cancer
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Medicine In Prostate Cancer
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Medicine In Prostate Cancer (2011-2021)
  1.4.1 United States Medicine In Prostate Cancer Sales and Growth Rate (2011-2021)
  1.4.2 United States Medicine In Prostate Cancer Revenue and Growth Rate (2011-2021)

2 UNITED STATES MEDICINE IN PROSTATE CANCER COMPETITION BY MANUFACTURERS

2.1 United States Medicine In Prostate Cancer Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Medicine In Prostate Cancer Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Medicine In Prostate Cancer Average Price by Manufactures (2015 and 2016)
2.4 Medicine In Prostate Cancer Market Competitive Situation and Trends
  2.4.1 Medicine In Prostate Cancer Market Concentration Rate
  2.4.2 Medicine In Prostate Cancer Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MEDICINE IN PROSTATE CANCER SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Medicine In Prostate Cancer Sales and Market Share by Type (2011-2016)
3.2 United States Medicine In Prostate Cancer Revenue and Market Share by Type (2011-2016)
3.3 United States Medicine In Prostate Cancer Price by Type (2011-2016)
3.4 United States Medicine In Prostate Cancer Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MEDICINE IN PROSTATE CANCER SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Medicine In Prostate Cancer Sales and Market Share by Application (2011-2016)
4.2 United States Medicine In Prostate Cancer Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MEDICINE IN PROSTATE CANCER MANUFACTURERS PROFILES/ANALYSIS

5.1 Bristol-Myers Squibb
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bristol-Myers Squibb Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AstraZeneca
  5.2.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AstraZeneca Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Eli Lilly
  5.3.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Eli Lilly Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Roche
  5.4.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Roche Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 GSK
  5.5.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 GSK Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Novartis
  5.6.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Novartis Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Pfizer
  5.7.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Pfizer Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Sanofi
  5.8.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Sanofi Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Bayer
  5.9.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Bayer Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Celgene
  5.10.2 Medicine In Prostate Cancer Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Celgene Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 MEDICINE IN PROSTATE CANCER MANUFACTURING COST ANALYSIS

6.1 Medicine In Prostate Cancer Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Medicine In Prostate Cancer

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Medicine In Prostate Cancer Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Medicine In Prostate Cancer Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MEDICINE IN PROSTATE CANCER MARKET FORECAST (2016-2021)

10.1 United States Medicine In Prostate Cancer Sales, Revenue Forecast (2016-2021)
10.2 United States Medicine In Prostate Cancer Sales Forecast by Type (2016-2021)
10.3 United States Medicine In Prostate Cancer Sales Forecast by Application (2016-2021)
10.4 Medicine In Prostate Cancer Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Medicine In Prostate Cancer
Table Classification of Medicine In Prostate Cancer
Figure United States Sales Market Share of Medicine In Prostate Cancer by Type in 2015
Table Application of Medicine In Prostate Cancer
Figure United States Sales Market Share of Medicine In Prostate Cancer by Application in 2015
Figure United States Medicine In Prostate Cancer Sales and Growth Rate (2011-2021)
Figure United States Medicine In Prostate Cancer Revenue and Growth Rate (2011-2021)
Table United States Medicine In Prostate Cancer Sales of Key Manufacturers (2015 and 2016)
Table United States Medicine In Prostate Cancer Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Medicine In Prostate Cancer Sales Share by Manufacturers
Figure 2016 Medicine In Prostate Cancer Sales Share by Manufacturers
Table United States Medicine In Prostate Cancer Revenue by Manufacturers (2015 and 2016)
Table United States Medicine In Prostate Cancer Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Medicine In Prostate Cancer Revenue Share by Manufacturers
Table 2016 United States Medicine In Prostate Cancer Revenue Share by Manufacturers
Table United States Market Medicine In Prostate Cancer Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Medicine In Prostate Cancer Average Price of Key Manufacturers in 2015
Figure Medicine In Prostate Cancer Market Share of Top 3 Manufacturers
Figure Medicine In Prostate Cancer Market Share of Top 5 Manufacturers
Table United States Medicine In Prostate Cancer Sales by Type (2011-2016)
Table United States Medicine In Prostate Cancer Sales Share by Type (2011-2016)
Figure United States Medicine In Prostate Cancer Sales Market Share by Type in 2015
Table United States Medicine In Prostate Cancer Revenue and Market Share by Type (2011-2016)
Table United States Medicine In Prostate Cancer Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Medicine In Prostate Cancer by Type (2011-2016)
Table United States Medicine In Prostate Cancer Price by Type (2011-2016)
Figure United States Medicine In Prostate Cancer Sales Growth Rate by Type (2011-2016)
Table United States Medicine In Prostate Cancer Sales by Application (2011-2016)
Table United States Medicine In Prostate Cancer Sales Market Share by Application (2011-2016)
Figure United States Medicine In Prostate Cancer Sales Market Share by Application in 2015
Table United States Medicine In Prostate Cancer Sales Growth Rate by Application (2011-2016)
Figure United States Medicine In Prostate Cancer Sales Growth Rate by Application (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table Celgene Basic Information List
Table Celgene Medicine In Prostate Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Medicine In Prostate Cancer Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Medicine In Prostate Cancer
Figure Manufacturing Process Analysis of Medicine In Prostate Cancer
Figure Medicine In Prostate Cancer Industrial Chain Analysis
Table Raw Materials Sources of Medicine In Prostate Cancer Major Manufacturers in 2015
Table Major Buyers of Medicine In Prostate Cancer
Table Distributors/Traders List
Figure United States Medicine In Prostate Cancer Production and Growth Rate Forecast (2016-2021)
Figure United States Medicine In Prostate Cancer Revenue and Growth Rate Forecast (2016-2021)
Table United States Medicine In Prostate Cancer Production Forecast by Type (2016-2021)
Table United States Medicine In Prostate Cancer Consumption Forecast by Application (2016-2021)